SPECTRUM PHARMACEUTICALS INC (SPPI)

Overview Price 13.48 Price Change Today 0.00 (0.00%) P&P rating Zacks Rank 1 - STRONG BUY Open Price $0.00 Previous Close $13.48 Daily Range $0.00 - $0.00 52-Week Range $6.42 - $16.00 Volume 0 Spectrum Pharmaceuticals, Inc. is opportunistically acquiring and advancing a diversified portfolio of oncology drug candidates that meet critical health challenges for which there are few other treatment options. Spectrum's expertise lies in identifying undervalued drugs with demonstrated safety and efficacy, and adding value through further clinical development and selection of the most viable and low-risk methods of commercialization. The company's pipeline includes promising early and late-stage drug candidates with unique formulations and mechanisms of action that address the needs of seriously ill patients, such as at-home chemotherapy and new treatment regimens for refractory disease. Other Resources for SPPI Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary Zacks Blog: Zacks Releases Four Powerful ''Buy'' Stocks: ExlService Holdings, Seagate Technology plc, Spectrum Pharmaceuticals and Textainer Group Holdings November 9, 2011 Zacks Blog: Bullish MACD for Spectrum Pharma October 14, 2011 Zacks Blog: Zacks Releases Four Powerful ''Buy'' Stocks: OM Group, Magna International, Spectrum Pharmaceuticals and World Acceptance July 14, 2011 Zacks Blog: Cancer Study to Continue at SPPI April 4, 2011 Zacks Blog: Endo Pharma Starts Cancer Trial February 17, 2011 Spectrum Pharmaceuticals, Inc. is opportunistically acquiring and advancing a diversified portfolio of oncology drug candidates that meet critical health challenges for which there are few other treatment options. Spectrum's expertise lies in identifying undervalued drugs with demonstrated safety and efficacy, and adding value through further clinical development and selection of the most viable and low-risk methods of commercialization. The company's pipeline includes promising early and late-stage drug candidates with unique formulations and mechanisms of action that address the needs of seriously ill patients, such as at-home chemotherapy and new treatment regimens for refractory disease.   Brokerage Analyst Recommendations 4 Brokerage Firms Covering SPPI   Strong Buy 3 Buy 1 Hold 0 Sell 0 Strong Sell 0 Average Broker Recommendation (ABR): 1.25   SPPI Ratings: BUY  SELL  HOLD SPPI Consensus Forecasts

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 17 Buy 1 Sell   Top Buy Analysis BUY: SPPI Company: SPECTRUM PHARMACEUTICALS INC. Points: 22.09 Start Price: $10.73 Start Date: 07/18/2011 11:30 PM SteveHarm P&P Score: 99.49 Recs: Zacks rack 1 (looks good short term Zack Rec 1 ( looks good longer term) Current Ratio 1.99 (can cover it's debts) Debt/Equity 0.0 (No debt, excellent) ROE 17.15% (very good) Oper Margin 11.86 % (excellent) relative strength 92% (doing well vs. S&P past month) Comments: 0 | Comment More Recent Analysis Top Sell Analysis SELL: SPPI Company: SPECTRUM PHARMACEUTICALS INC. Points: -99.23 Start Price: $5.40 Start Date: 07/03/2009 11:48 PM NegativeOne P&P Score: 1.08 Recs: Comments: 0 | Comment More Recent Analysis

Blog Posts

User	User Score	Date	Title	Comments	Last Comment
franklinqq	0.00	11/30/09	DYAX—Will It be the Next 10x Myth?	0
Zacks_Analysts	0.00	04/04/11	Cancer Study to Continue at SPPI - Analyst Blog	0
Zacks_Analysts	0.00	02/17/11	Endo Pharma Starts Cancer Trial - Analyst Blog	0
Zacks_Analysts	0.00	11/30/10	Good News for Spectrum Pharma - Analyst Blog	0
Zacks_Analysts	0.00	04/07/10	Spectrum Beats by a Penny - Analyst Blog	0
Zacks_Analysts	0.00	10/13/09	Disappointment for Spectrum - Analyst Blog	0
Zacks_Analysts	0.00	08/31/09	Trubion Drug to be Co-developed - Analyst Blog	0
Zacks_Analysts	0.00	07/27/09	Allergan Drug Gets Fast-Tracked - Analyst Blog	0
Zacks_Analysts	0.00	07/14/09	Cell Therapeutics Awaits Approval - Analyst Blog	0

Commentary

BUY: SPECTRUM PHARMACEUTICALS INC. (SPPI) Start Price: $15.67 Points: -18.31 Created: 01/12/2012 Bullish. Comments: 0 | Comment Bigme11 Recs:

BUY: SPECTRUM PHARMACEUTICALS INC. (SPPI) Start Price: $10.73 Points: +22.09 Created: 07/18/2011 Zacks rack 1 (looks good short term Zack Rec 1 ( looks good longer term) Current Ratio 1.99 (can cover it's debts) Debt/Equity 0.0 (No debt, excellent) ROE 17.15% (very good) Oper Margin 11.86 % (excellent) relative strength 92% (doing well vs. S&P past month) Comments: 0 | Comment SteveHarm Recs:

BUY: SPECTRUM PHARMACEUTICALS INC. (SPPI) Start Price: $7.64 Points: +75.62 Created: 05/18/2011 It's touch the 7.2 resistance yesterday and today it's recovering again Comments: 3 | Comment Whitestar Recs:

BUY: SPECTRUM PHARMACEUTICALS INC. (SPPI) Start Price: $6.98 Points: +91.34 Created: 02/15/2011 Broke out on volume Comments: 0 | Comment wallstreeter Recs:

BUY: SPECTRUM PHARMACEUTICALS INC. (SPPI) Start Price: $4.21 Points: +195.92 Created: 05/23/2010 increased sales and profits Comments: 0 | Comment mdmoney Recs:

BUY: SPECTRUM PHARMACEUTICALS INC. (SPPI) Start Price: $4.46 Points: +188.31 Created: 04/08/2010 i believe it is going up.soon Comments: 0 | Comment homedaddyjake Recs:

BUY: SPECTRUM PHARMACEUTICALS INC. (SPPI) Start Price: $8.76 Points: +18.00 Created: 09/02/2009 This stock can swim or drown. Be very careful. Comments: 0 | Comment Aldecoa Recs:

BUY: SPECTRUM PHARMACEUTICALS INC. (SPPI) Start Price: $6.28 Points: +79.00 Created: 08/19/2009 future value pick Comments: 0 | Comment FedeTech Recs:

BUY: SPECTRUM PHARMACEUTICALS INC. (SPPI) Start Price: $14.51 Points: -17.92 Created: 12/15/2011 ds Comments: 0 | Comment Yade Recs:

SELL: SPECTRUM PHARMACEUTICALS INC. (SPPI) Start Price: $5.40 Points: -99.23 Created: 07/03/2009 Comments: 0 | Comment NegativeOne Recs:

Pages: [ 1 ]  2  >>

Picks

Username	P&P Score	Call	Time Frame	Start Date	Start Price	Today (change)	Stock Gain	S&P Gain	Points	Analysis
Bigme11	2.71	BUY	Three to Six Months	01/12/2012	$15.67	$13.48 (-3.30%)	-13.98%	+4.34%	-18.31	view close
Yade	99.88	BUY	One to Three Years	12/15/2011	$14.51	$13.48 (-3.30%)	-7.10%	+10.82%	-17.92	view close
SteveHarm	99.49	BUY	Six Months to a Year	07/18/2011	$10.73	$13.48 (-3.30%)	+25.63%	+3.54%	+22.09	view close
Whitestar	98.52	BUY	Week or Less	05/18/2011	$7.64	$13.48 (-3.30%)	+76.44%	+0.82%	+75.62	view close
wallstreeter	0.23	BUY	Three to Six Months	02/15/2011	$6.98	$13.48 (-3.30%)	+93.12%	+1.78%	+91.34	view close
mdmoney	98.37	BUY	Six Months to a Year	05/23/2010	$4.21	$13.48 (-3.30%)	+220.19%	+24.27%	+195.92	view close
homedaddyjake		BUY	Week or Less	04/08/2010	$4.46	$13.48 (-3.30%)	+202.24%	+13.93%	+188.31	view close
Aldecoa	0.39	BUY	Three Plus Years	09/02/2009	$8.76	$13.48 (-3.30%)	+53.88%	+35.88%	+18.00	view close
FedeTech	99.46	BUY	One to Three Years	08/19/2009	$6.28	$13.48 (-3.30%)	+114.65%	+35.65%	+79.00	view close
NegativeOne	1.08	SELL	Week to a Month	07/03/2009	$5.40	$13.48 (-3.30%)	+149.63%	+50.40%	-99.23

Pages: [ 1 ]  2  >>